Groups Debate Whether House Cannabis Bill Would Hinder FDA Oversight

The House on Friday (July 31) passed 217-197 a fiscal 2021 funding bill containing a cannabis provision that one group argued would effectively prevent FDA from enforcing product safety standards. However, cannabis organizations say the group’s take on the provision is flawed because FDA, though it cannot regulate cannabis, can take action against cannabidiol companies, regardless of the amendment. At issue is an amendment House lawmakers voted Thursday evening (July 30) to include in a six-bill appropriations minibus that funds...